Listen: 23andMe is going public, vaccine data abound, and Merck’s CEO is retiring February 4, 2021 San Francisco Biotechnology Network News News Comments Off on Listen: 23andMe is going public, vaccine data abound, and Merck’s CEO is retiring Is consumer DNA testing a good business? Are Covid-19 vaccines interchangeable? And how do you IQ-test an artificial intelligence? Find out on the latest episode of "The Readout LOUD." Listen… Click to view original post The Readout LOUDCoronavirusdementiafinancegenetics